Answers are grounded in this paper and cite their sources.
Retrospective analysis demonstrates effective management of benign tumors in the jugular foramen region, suggesting new surgical options.
Background: The transcervical transparotid approach was developed for management of lesions in the parapharyngeal space, while its application for addressing lesions at the jugular foramen region (JFR) has not been sufficiently assessed. This study retrospectively reviewed the clinical outcomes of eight patients who underwent an endoscopic-assisted transcervical transparotid approach (EATTA) for management of lesions at the JFR. Methods: The study comprised a retrospective analysis of patients who underwent an EATTA for management of lesions at the JFR. The demographics and peri-operative related indices were analyzed. Results: Benign tumors at the JFR in eight patients were completely removed via EATTA, including two primary and six recurrences. An expanded jugular foramen was detected in three patients. The endoscopic assistance could help enhance exposure of the residual lesions at the JFR and those that extended to the posterior cranial fossa via the expanded foramen. Worsening of pre-existing hoarseness (n=5) and new emergence of Horner syndrome (n=1) were observed. No intra-operative inadvertent carotid artery injury or CSF leak occurred. Temporary facial nerve palsy was observed in 6 patients and resolved uneventfully. No recurrence occurred with an average follow up of 23 months. Conclusion: An EATTA serves as an alternative for management of benign tumors at the JFR. For select lesions, this approach can also address lesions extending to the posterior cranial fossa via an expanded jugular foramen.
No takes yet. Share an insight, caveat, or question.
Kou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: